Low molecular weight heparins for acute coronary syndrome: Tackling the issues head-on

被引：9

作者：

Antman, EM

机构：

[1] Brigham & Womens Hosp, Samuel A Levine Cardiac Unit, Boston, MA 02115 USA

[2] Harvard Med Sch, Boston, MA USA

来源：

AMERICAN HEART JOURNAL | 2003年 / 146卷 / 02期

关键词：

D O I：

10.1016/S0002-8703(03)00180-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：191 / 193

页数：3

共 15 条

[1] Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction - Results of the thrombolysis in myocardial infarction (TIMI) 11B trial [J].

Antman, EM ;

McCabe, CH ;

Gurfinkel, EP ;

Turpie, AGG ;

Bernink, PJLM ;

Salein, D ;

de Luna, AB ;

Fox, K ;

Lablanche, JM ;

Radley, D ;

Premmereur, J ;

Braunwald, E .

CIRCULATION, 1999, 100 (15) :1593-1601

[2] Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction - TIMI 11B-ESSENCE meta-analysis [J].

Antman, EM ;

Cohen, M ;

Radley, D ;

McCabe, C ;

Rush, J ;

Premmereur, J ;

Braunwald, E .

CIRCULATION, 1999, 100 (15) :1602-1608

[3] Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE [J].

Antman, EM ;

Cohen, M ;

McCabe, C ;

Goodman, SG ;

Murphy, SA ;

Braunwald, E .

EUROPEAN HEART JOURNAL, 2002, 23 (04) :308-314

[4]

Antman EM, 2001, CIRCULATION, V103, P2310

[5] Anticoagulant pharmacodynamics of tinzaparin following 175 IU/kg subcutaneous administration to healthy volunteers [J].

Barrett, JS ;

Hainer, JW ;

Kornhauser, DM ;

Gaskill, JL ;

Hua, TA ;

Sprogel, P ;

Johansen, K ;

van Lier, JJ ;

Knebel, W ;

Pieniaszek, HJ .

THROMBOSIS RESEARCH, 2001, 101 (04) :243-254

[6]

Braunwald E, 1997, J AM COLL CARDIOL, V29, P1474

[7] ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) [J].

Braunwald, E ;

Antman, EM ;

Beasley, JW ;

Califf, RM ;

Cheitlin, MD ;

Hochman, JS ;

Jones, RH ;

Kereiakes, D ;

Kupersmith, J ;

Levin, TN ;

Pepine, CJ ;

Schaeffer, JW ;

Smith, EE ;

Steward, DE ;

Theroux, P ;

Gibbons, RJ ;

Alpert, JS ;

Faxon, DP ;

Fuster, V ;

Gregoratos, G ;

Hiratzka, LF ;

Jacobs, AK ;

Smith, SC .

CIRCULATION, 2002, 106 (14) :1893-1900

[8] Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without St elevation: a meta-analysis [J].

Eikelboom, JW ;

Anand, SS ;

Malmberg, K ;

Weitz, JI ;

Ginsberg, JS ;

Yusuf, S .

LANCET, 2000, 355 (9219) :1936-1942

[9] The SYNERGY trial: Study design and rationale [J].

Ferguson, JJ ;

Califf, RM ;

Antman, EM ;

Cohen, M ;

Grines, CL ;

Kereiakes, DJ ;

Langer, A ;

Mahaffey, KW ;

Nessel, CC ;

Rios-Nogales, L .

AMERICAN HEART JOURNAL, 2002, 143 (06) :952-960

[10] Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention [J].

Fox, KAA ;

Antman, EM ;

Cohen, M ;

Bigonzi, F .

AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (05) :477-482

← 1 2 →